Financial News
Articles published by Immuron Limited

Immuron CEO, Steven Lydeamore Investor Webinar Presentation
November 28, 2023
From Immuron Limited
Via GlobeNewswire

Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
From Immuron Limited
Via GlobeNewswire

Immuron CEO Steven Lydeamore presented at AusBioInvest
October 30, 2023
From Immuron Limited
Via GlobeNewswire

Immuron Announces Travelan® Clinical Study Cohort 2 commences
October 18, 2023
From Immuron Limited
Via GlobeNewswire

Immuron achieves record quarterly Travelan® sales
October 11, 2023
From Immuron Limited
Via GlobeNewswire

Immuron achieves record monthly Travelan® sales
September 13, 2023
From Immuron Limited
Via GlobeNewswire

Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
September 11, 2023
From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire

Immuron CEO, Steven Lydeamore to present at Bioshares
July 24, 2023
From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire



Immuron Business Update: Letter to Shareholders
June 22, 2023
From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire


From Immuron Limited
Via GlobeNewswire




Immuron CEO, Steven Lydeamore to host an investor webinar
February 15, 2023
From Immuron Limited
Via GlobeNewswire




Immuron Receives FDA Approval for Travelan IND Application
December 23, 2022
From Immuron Limited
Via GlobeNewswire

Immuron Submits IND Application To FDA for Travelan
December 05, 2022
From Immuron Limited
Via GlobeNewswire

Immuron completes strategic investment in leading gut health biotech Ateria Health
November 16, 2022
From Immuron Limited
Via GlobeNewswire

Immuron CEO, Steven Lydeamore to present at AusBioInvest
October 26, 2022
From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire

From Immuron Limited
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.